KRAS, NRAS and BRAF Mutation Prevalence and its Clinicopathological Association in Colorectal Carcinoma with Emphasis on Tumor Budding

被引：0
|
作者：
Ghafoor, Mariam [1 ]
Ajmal, Namra [1 ]
Wang, Zixuan [2 ]
Bashir, Babar [3 ]
Lin, Daniel [3 ]
Peiper, Stephen [4 ]
Jiang, Wei [1 ]
Ambelil, Manju [2 ]
机构：
[1] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA
[4] Sidney Kimmel Med Coll, Philadelphia, PA USA
来源：
MODERN PATHOLOGY | 2022年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
422
引用
收藏
页码：458 / 459
页数：2
相关论文
共 50 条
  • [41] The Clinicopathological Correlation of KRAS Mutation and PTEN Expression Status in Primary and Metastatic Colorectal Carcinoma
    Hassan, Redir T.
    AL Hassawi, Bashar
    Alkazzaz, Maysoon
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [42] The prognostic significance of growth pattern, tumor budding, poorly differentiated clusters, desmoplastic reaction pattern and tumor-stroma ratio in colorectal cancer and an evaluation of their relationship with KRAS, NRAS, BRAF mutations
    Kocabey, Duygu Unal
    Cakir, I. Ebru
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 73
  • [43] Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer
    Wu, Jing-Bo
    Li, Xiao-Jing
    Liu, Hui
    Liu, Yong-Juan
    Liu, Xiu-Ping
    BIOMEDICAL REPORTS, 2023, 19 (06)
  • [44] Invasive Implants of Ovarian Serous Borderline Tumor: Significant Association with KRAS but Not BRAF Mutation
    Zuo, Tao
    Wong, Serena
    Buza, Natalia
    Hui, Pei
    MODERN PATHOLOGY, 2017, 30 : 319A - 319A
  • [45] Invasive Implants of Ovarian Serous Borderline Tumor: Significant Association with KRAS but Not BRAF Mutation
    Zuo, Tao
    Wong, Serena
    Buza, Natalia
    Hui, Pei
    LABORATORY INVESTIGATION, 2017, 97 : 319A - 319A
  • [46] Tumor profiling of KRAS, BRAF, and NRAS gene mutations in patients with colorectal cancer: A Lebanese major center cohort study
    Baba, Omar
    Bidikian, Aram
    Mukherji, Deborah
    Shamseddin, Ali
    Temraz, Sally
    Fakhruddin, Najla
    Khazzouh, Mira
    Ghizzawi, Diana
    Khalek, Rabab Abdel
    Zaatari, Ghazi
    Mahfouz, Rami
    GENE, 2022, 834
  • [47] Factors associated with disconcordance of KRAS, NRAS, BRAF, PIK3CA mutation status in the primary tumor and metastases in patients (pts) with colorectal cancer (CRC)
    Fedyanin, M.
    Stroganova, A.
    Senderovich, A.
    Dranko, S.
    Tryakin, A.
    Polyanskaya, E.
    Popova, A.
    Sekhina, O.
    Rasulov, A.
    Gordeev, S.
    Sagaydak, I.
    Tjulandin, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [48] Concordance of KRAS, NRAS, BRAF, PIK3CA mutation status in the primary tumor (PT) and metachronous metastases in patients (pts) with colorectal cancer (CRC)
    Fedyanin, Mikhail
    Stroganova, Anna
    Senderovich, Anastasia
    Dranko, Svetlana
    Tryakin, Alexey
    Pokataev, Ilya
    Polyanskaya, Elizaveta
    Gordeev, Sergey
    Rasulov, Arsen
    Polyakov, Alex
    Sagaydak, Igor
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] A Retrospective Study of Association of Tumor Budding, Tumor Microenvironment, and Clinicopathological Characteristics of Invasive Breast Carcinoma
    Singh, Tanwi
    Chandra, Kalpana
    Kumar, Nidhish
    Mishra, Anuja
    Singh, Sanjeet
    Singh, Anju
    Kumar, Umesh
    Kumar, Praveen
    JOURNAL OF LABORATORY PHYSICIANS, 2022, 14 (04) : 485 - 490
  • [50] Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
    Fang Guo
    Hai Gong
    Huanhuan Zhao
    Jing Chen
    Yiming Zhang
    Lihua Zhang
    Xin Shi
    Aifeng Zhang
    Hui Jin
    Jianqiong Zhang
    Youji He
    Scientific Reports, 8
12345